Gray, G.EMngadi, KLavreys, LLuedtke, ANijs, SStieh, DJuraska, MHyrien, OSwann, ETomaras, GMcElrath, JPau, M.GBuchbinder, S.PTomaka, K2024-10-042024-10-042022-02-16https://www.croiwebcasts.org/p/2022croi/croi/121https://hdl.handle.net/11288/597787Conference on Retroviruses and Opportunistic Infections (CROI) 12-16 Feburary 2022.Imbokodo is the first trial evaluating clinical efficacy of a heterologous HIV-1 vaccine regimen consisting of an Ad26 vector (Ad26.Mos4.HIV) expressing mosaic.enHIV-1VaccineAfrican WomenHIV preventionPresentation